North America Cellulite Treatment Market Forecast 2023-2032

The North America cellulite treatment market is estimated to develop with a CAGR of 9.54% during the forecasted period of 2023-2032. The market growth of the region is fueled by the availability of a significant number of plastic surgeons, the presence of well-established market players and the strategic initiatives undertaken by these companies.

MARKET INSIGHTS

The North America cellulite treatment market growth analysis constitutes a detailed assessment of Canada and the United States. The high number of obesity cases in Canada is expected to drive the demand for cellulite treatments in the country. Moreover, according to Statistics Canada, more than 26% of adults in the country were obese in 2018. This number is expected to rise mainly due to unhealthy eating habits and lack of physical exercise, thus further propelling the market growth.

On the other hand, since obesity increases with age, the surge in Canada's geriatric population is expected to fuel the need for cellulite treatment products. Accordingly, as per the Government of Canada, the nation had around 6.6 million seniors in the year 2019, with the geriatric population set to reach close to one-fourth of the overall populace by the year 2040. Therefore, the abovementioned factors are set to boost the North America cellulite treatment market growth during the estimated period.

COMPETITIVE INSIGHTS

Some of the leading companies operating in the market are: AbbVie Inc, Cutera Inc, Johnson & Johnson, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 50821

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
- 2.5.1. RISING BEAUTY CONSCIOUSNESS
- 2.5.2. GROWING PREFERENCE TOWARDS NON-INVASIVE PROCEDURES
- 2.5.3. RAPID TECHNOLOGICAL ADVANCEMENTS TO PROMOTE MARKET GROWTH
- 2.5.4. RAPIDLY CHANGING LIFESTYLES LEADING TO OBESITY

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. GROWING DEMAND FOR AESTHETIC AND COSMETIC PROCEDURES
- 3.1.2. RISING CASES OF OBESITY
- 3.1.3. RAPIDLY BOOMING MEDICAL TOURISM INDUSTRY
3.2. KEY RESTRAINTS
- 3.2.1. HIGH COST OF ADVANCED CELLULITE TREATMENT
- 3.2.2. SIDE EFFECTS POST-TREATMENT
- 3.2.3. LACK OF AWARENESS

4. KEY ANALYTICS

4.1. PARENT MARKET ANALYSIS
4.2. KEY TECHNOLOGY TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
- 4.3.1. BUYERS POWER
- 4.3.2. SUPPLIERS POWER
- 4.3.3. SUBSTITUTION
- 4.3.4. NEW ENTRANTS
- 4.3.5. INDUSTRY RIVALRY
4.4. GROWTH PROSPECT MAPPING
4.5. MARKET MATURITY ANALYSIS
4.6. MARKET CONCENTRATION ANALYSIS
4.7. VALUE CHAIN ANALYSIS
- 4.7.1. RESEARCH AND DEVELOPMENT
- 4.7.2. PRODUCT DEVELOPMENT
- 4.7.3. MARKETING AND DISTRIBUTION
- 4.7.4. POST-SALES MONITORING
4.8. KEY BUYING CRITERIA
- 4.8.1. COST
- 4.8.2. BRAND REPUTATION
- 4.8.3. USABILITY

5. MARKET BY PROCEDURE

5.1. NON-INVASIVE
5.2. MINIMALLY INVASIVE
5.3. TOPICAL

6. MARKET BY TYPE

6.1. SOFT CELLULITE
6.2. HARD CELLULITE
6.3. EDEMATOUS CELLULITE

7. MARKET BY END-USER

7.1. HOSPITALS
7.2. CLINICS AND BEAUTY CENTERS
7.3. OTHER END-USERS

8. GEOGRAPHICAL ANALYSIS

8.1. NORTH AMERICA
- 8.1.1. MARKET SIZE & ESTIMATES
- 8.1.2. NORTH AMERICA CELLULITE TREATMENT MARKET DRIVERS
- 8.1.3. NORTH AMERICA CELLULITE TREATMENT MARKET CHALLENGES
- 8.1.4. NORTH AMERICA CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
- 8.1.5. KEY PLAYERS IN NORTH AMERICA CELLULITE TREATMENT MARKET
- 8.1.6. COUNTRY ANALYSIS
  - 8.1.6.1. UNITED STATES
  - 8.1.6.1.1. UNITED STATES CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
  - 8.1.6.2. CANADA
  - 8.1.6.2.1. CANADA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES

9. COMPETITIVE LANDSCAPE

9.1. KEY STRATEGIC DEVELOPMENTS
- 9.1.1. ACQUISITIONS
- 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 9.1.3. PARTNERSHIPS & AGREEMENTS
- 9.1.4. EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
- 9.2.1. ABBVIE INC
  - 9.2.1.1. COMPANY OVERVIEW
  - 9.2.1.2. FINANCIAL ANALYSIS
  - 9.2.1.3. PRODUCTS / SERVICES LIST
  - 9.2.1.4. STRENGTHS & CHALLENGES
- 9.2.2. ALMA LASERS
  - 9.2.2.1. COMPANY OVERVIEW
  - 9.2.2.2. PRODUCTS / SERVICES LIST
- 9.2.3. BAUSCH HEALTH COMPANIES INC.
  - 9.2.3.1. COMPANY OVERVIEW
  - 9.2.3.2. FINANCIAL ANALYSIS
  - 9.2.3.3. PRODUCTS / SERVICES LIST
  - 9.2.3.4. STRENGTHS & CHALLENGES
- 9.2.4. CANDELA CORPORATION
  - 9.2.4.1. COMPANY OVERVIEW
  - 9.2.4.2. PRODUCTS / SERVICES LIST
  - 9.2.4.3. STRENGTHS & CHALLENGES
- 9.2.5. CUTERA INC
  - 9.2.5.1. COMPANY OVERVIEW
  - 9.2.5.2. FINANCIAL ANALYSIS
  - 9.2.5.3. PRODUCTS / SERVICES LIST
  - 9.2.5.4. STRENGTHS & CHALLENGES
- 9.2.6. CYNOSURE LLC
  - 9.2.6.1. COMPANY OVERVIEW
  - 9.2.6.2. PRODUCTS / SERVICES LIST
  - 9.2.6.3. STRENGTHS & CHALLENGES
- 9.2.7. ENDO INTERNATIONAL PLC
  - 9.2.7.1. COMPANY OVERVIEW
  - 9.2.7.2. FINANCIAL ANALYSIS
  - 9.2.7.3. PRODUCTS / SERVICES LIST
  - 9.2.7.4. STRENGTHS & CHALLENGES
- 9.2.8. GALDERMA SA
  - 9.2.8.1. COMPANY OVERVIEW
  - 9.2.8.2. PRODUCTS / SERVICES LIST
  - 9.2.8.3. STRENGTHS & CHALLENGES
- 9.2.9. INCELER MEDIKAL CO LTD
  - 9.2.9.1. COMPANY OVERVIEW
  - 9.2.9.2. PRODUCTS / SERVICES LIST
  - 9.2.9.3. STRENGTHS & CHALLENGES
- 9.2.10. JOHNSON & JOHNSON
  - 9.2.10.1. COMPANY OVERVIEW
  - 9.2.10.2. FINANCIAL ANALYSIS
  - 9.2.10.3. PRODUCTS / SERVICES LIST
  - 9.2.10.4. STRENGTHS & CHALLENGES
- 9.2.11. MERZ PHARMA GMBH & CO KGAA
  - 9.2.11.1. COMPANY OVERVIEW
  - 9.2.11.2. PRODUCTS / SERVICES LIST
  - 9.2.11.3. STRENGTHS & CHALLENGES
- 9.2.12. NUBWAY CO LTD
  - 9.2.12.1. COMPANY OVERVIEW
  - 9.2.12.2. PRODUCTS / SERVICES LIST
- 9.2.13. SIENTRA INC
  - 9.2.13.1. COMPANY OVERVIEW
  - 9.2.13.2. FINANCIAL ANALYSIS
  - 9.2.13.3. PRODUCTS / SERVICES LIST
  - 9.2.13.4. STRENGTHS & CHALLENGES
- 9.2.14. SINCLAIR PHARMA
  - 9.2.14.1. COMPANY OVERVIEW
  - 9.2.14.2. PRODUCTS / SERVICES LIST
- 9.2.15. ZIMMER MEDIZINSYSTEME
  - 9.2.15.1. COMPANY OVERVIEW
  - 9.2.15.2. PRODUCTS / SERVICES LIST
  - 9.2.15.3. STRENGTHS & CHALLENGES

Product Code: 50821

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - CELLULITE TREATMENT
TABLE 2: NORTH AMERICA CELLULITE TREATMENT MARKET, BY PROCEDURE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: NORTH AMERICA CELLULITE TREATMENT MARKET, BY PROCEDURE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 4: NORTH AMERICA CELLULITE TREATMENT MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: NORTH AMERICA CELLULITE TREATMENT MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: NORTH AMERICA CELLULITE TREATMENT MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: NORTH AMERICA CELLULITE TREATMENT MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 10: NORTH AMERICA CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
TABLE 11: LEADING PLAYERS OPERATING IN NORTH AMERICA CELLULITE TREATMENT MARKET
TABLE 12: LIST OF ACQUISITIONS
TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 14: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 15: LIST OF EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY TECHNOLOGY TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: VALUE CHAIN ANALYSIS
FIGURE 7: KEY BUYING CRITERIA
FIGURE 8: NORTH AMERICA CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY PROCEDURE, IN 2022
FIGURE 9: NORTH AMERICA CELLULITE TREATMENT MARKET, BY NON-INVASIVE, 2023-2032 (IN $ MILLION)
FIGURE 10: NORTH AMERICA CELLULITE TREATMENT MARKET, BY MINIMALLY INVASIVE, 2023-2032 (IN $ MILLION)
FIGURE 11: NORTH AMERICA CELLULITE TREATMENT MARKET, BY TOPICAL, 2023-2032 (IN $ MILLION)
FIGURE 12: NORTH AMERICA CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY TYPE, IN 2022
FIGURE 13: NORTH AMERICA CELLULITE TREATMENT MARKET, BY SOFT CELLULITE, 2023-2032 (IN $ MILLION)
FIGURE 14: NORTH AMERICA CELLULITE TREATMENT MARKET, BY HARD CELLULITE, 2023-2032 (IN $ MILLION)
FIGURE 15: NORTH AMERICA CELLULITE TREATMENT MARKET, BY EDEMATOUS CELLULITE, 2023-2032 (IN $ MILLION)
FIGURE 16: NORTH AMERICA CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2022
FIGURE 17: NORTH AMERICA CELLULITE TREATMENT MARKET, BY HOSPITALS, 2023-2032 (IN $ MILLION)
FIGURE 18: NORTH AMERICA CELLULITE TREATMENT MARKET, BY CLINICS AND BEAUTY CENTERS, 2023-2032 (IN $ MILLION)
FIGURE 19: NORTH AMERICA CELLULITE TREATMENT MARKET, BY OTHER END-USERS, 2023-2032 (IN $ MILLION)
FIGURE 20: NORTH AMERICA CELLULITE TREATMENT MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
FIGURE 21: UNITED STATES CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 22: CANADA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 23: ABBVIE INC COMPANY PROFIT 2017 - 2021 ($ BILLION)
FIGURE 24: ABBVIE INC COMPANY REVENUE - BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 25: ABBVIE INC COMPANY REVENUE - BY SEGMENT, 2021 (IN %)
FIGURE 26: BAUSCH HEALTH COMPANIES INC COMPANY PROFIT 2017 - 2021 ($ BILLION)
FIGURE 27: BAUSCH HEALTH COMPANIES INC COMPANY REVENUE - BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 28: BAUSCH HEALTH COMPANIES INC COMPANY REVENUE - BY SEGMENT, 2021 (IN %)
FIGURE 29: CUTERA INC COMPANY PROFIT 2017 - 2021 ($ MILLION)
FIGURE 30: CUTERA INC COMPANY REVENUE - BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 31: CUTERA INC COMPANY REVENUE - BY SEGMENT, 2021 (IN %)
FIGURE 32: ENDO INTERNATIONAL PLC COMPANY PROFIT 2018 - 2021 ($ MILLION)
FIGURE 33: ENDO INTERNATIONAL PLC COMPANY REVENUE - BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 34: ENDO INTERNATIONAL PLC COMPANY REVENUE - BY SEGMENT, 2021 (IN %)
FIGURE 35: JOHNSON & JOHNSON COMPANY PROFIT 2017 - 2021 ($ BILLION)
FIGURE 36: JOHNSON & JOHNSON COMPANY REVENUE - BY SEGMENT, 2021 (IN %)
FIGURE 37: JOHNSON & JOHNSON COMPANY REVENUE 2017 - 2021 ($ BILLION)
FIGURE 38: JOHNSON & JOHNSON COMPANY REVENUE - BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 39: SIENTRA INC COMPANY PROFIT 2017 - 2021 ($ MILLION)